| Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
|---|
| 03/03/2005 | US20050049248 Method of use of the compound that includes a conjugated polyene with between 7 to 14 double bonds, and cyclohexene rings with ether, phosphate, sulfate, dextran or other group which imparts water solubility; cancer, rheumatoid arthritis, stroke, cardiovascular inflammation |
| 03/03/2005 | US20050049202 For treating disorders associated with excessive cytokine release such as interleukin-1 (IL-1) for example infection, cancer, asthma, coronary restenosis, autoimmune disease, cirrhosis, entotoxemia, reperfusion injury and septic shock; lactone or lactam-benzoates or benzamides |
| 03/03/2005 | US20050048541 Using oligomeric sorting tags comprising repeat units and an increased affinity for stationary supports to separate preferential compounds within mixture; solid phase chemical synthesis |
| 03/03/2005 | US20050048135 Mixture containing plant extract; renin, angiogenesis inhibitor; cardiovascular disorders; antidiabetic agents; liver disorders; gall stones; gastrointestinal disorders |
| 03/03/2005 | CA2536089A1 Ppar modulators |
| 03/03/2005 | CA2535350A1 Acetylene derivatives as inhibitors of histone deacetylase |
| 03/03/2005 | CA2533396A1 3-aryl-4-hydroxyfuranone compounds and pharmaceutical and veterinary compositions containing them |
| 03/02/2005 | EP1510517A1 Process for the asymmetric hydrogenation of beta-amino ketones |
| 03/02/2005 | EP1510510A1 Method of substituent introduction through halogen-metal exchange reaction |
| 03/02/2005 | EP1509537A2 Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds and the compounds as such |
| 03/02/2005 | EP1509511A1 Manufacture of ascorbic acid esters |
| 03/02/2005 | EP1509497A1 Calcium receptor modulating arylalkylamines |
| 03/02/2005 | EP1509489A1 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof |
| 03/02/2005 | EP1509221A1 N-acylaminoacetonitrile derivatives and their use for controlling parasites |
| 03/02/2005 | EP1509218A1 Peptide deformylase inhibitors |
| 03/02/2005 | EP1392650B1 Protected tyrosine derivatives, method for the production thereof and use of the same for producing o-(2- ?18 f]-fluoroethyl)-l-tyrosine |
| 03/02/2005 | EP1172432B1 Perfume precursor compositions and method for expressing perfume components |
| 03/02/2005 | EP1042279B1 Substituted beta-alanines |
| 03/02/2005 | EP0991636B1 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities |
| 03/02/2005 | CN1589247A Method for preparing a composition containing at least an internal dehydrating product of a hydrogenated sugar |
| 03/02/2005 | CN1589153A Preventives/remedies for urinary disturbance |
| 03/02/2005 | CN1191243C Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 03/02/2005 | CN1191223C Vapour-phase partial oxidation aromatic hydrocarbons |
| 03/02/2005 | CN1191063C Antagonists for treatment of CD11/CD18 adhesion receptor mediated disorders |
| 03/01/2005 | US6861537 Tricyclic and tetracyclic taxane intermediates |
| 03/01/2005 | US6861527 Nitration in a static micromixer |
| 03/01/2005 | US6861444 Treating or preventing diabetes, obesity, hyperlipidemia, digestive diseases, depression or urinary disturbances; adrenergic blocking agents |
| 03/01/2005 | US6861424 A piperazine compound as antithrombotic agent |
| 03/01/2005 | US6861391 Pesticides and herbicides |
| 03/01/2005 | CA2289221C Labeled reagents for use in immunoassays and fluorescent compounds and complexes used therein |
| 03/01/2005 | CA2254788C Process for preparing phthalides |
| 02/24/2005 | WO2005016906A1 Process for the manufacture of rofecoxib |
| 02/24/2005 | WO2005016905A1 Improved method for the production of hydroxymatairesinol from wood |
| 02/24/2005 | WO2005016870A1 2-substituted benzoic acid derivatives as hm74a receptor agonists |
| 02/24/2005 | WO2005016862A1 Substituted arylalkanoic acid derivative and use thereof |
| 02/24/2005 | WO2005016277A2 Arylsulfonamidobenzylic compounds |
| 02/24/2005 | WO2005016264A2 Diamine derivatives of quinone and uses thereof |
| 02/24/2005 | WO2004099168A3 Substituted carboxylic acids |
| 02/24/2005 | US20050043551 Reacting furfural and nitromethane, with isobuthylamine as catalyst and activated coal as adsorbent; centrifugation; vacuum filtration; crystallization |
| 02/24/2005 | US20050043550 Process for the preparation of 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofuran carbonitrile |
| 02/24/2005 | US20050043544 Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same |
| 02/24/2005 | US20050043388 Therapy, prevention of metabolism disorders; insulin resistance; antidiabetic agents; hypoglycemic agents; anticholesterol agents; obesity; polycystic ovarian syndrome |
| 02/24/2005 | US20050043386 2-amino-2-(ethyl or methyl)-4-{5-substituted pyrrol-2-yl}butan-1-ols, phosphates and phosphonates; antiarthritic agents; psoriasis; immunosuppressants |
| 02/24/2005 | US20050043370 Therapy for acquired immune deficiency or aids related complex; compound containing ketone and carboxy groups |
| 02/24/2005 | US20050043304 Lower alkyl molecular weight amine as enzyme inhibitors for use in the treatment of tryptase enzyme inhibitors inhibitorsfor respiratory system disorders, antiinflammatory agents, inflammatory bowel disease, hyperprolific skin disorders, vascular edema and rheumatoid arthritis |
| 02/24/2005 | US20050043299 Inhibitors of dipeptidyl peptidase iv |
| 02/24/2005 | US20050043294 Treating atherosclerosis and other coronary artery diseases; preventing dyslipidemia |
| 02/24/2005 | DE10302452B4 Carbonylamino-substituierte Acyl-phenyl-harnstoffderivate, Verfahren zu deren Herstellung und deren Verwendung Carbonylamino-substituted acyl-phenyl-urea derivatives, processes for their preparation and their use |
| 02/24/2005 | CA2535665A1 Substituted arylalkanoic acid derivative and use thereof |
| 02/24/2005 | CA2535652A1 Substituted thiophenes and uses thereof |
| 02/24/2005 | CA2533638A1 Arylsulfonamidobenzylic compounds |
| 02/23/2005 | EP1507504A1 Cycloalkyl inhibitors of potassium channel function |
| 02/23/2005 | EP1041980B1 Acyl guanidine sodium/proton exchange inhibitors and method |
| 02/23/2005 | EP0876337B1 New lh-rh antagonists with improved effectiveness |
| 02/23/2005 | CN1585761A Hydrogenation of 3, 4-tetrahydrofurandiol to tetrahydrofuran |
| 02/23/2005 | CN1585760A Conversion of tetrahydroxybutane to tetrahydrofuran |
| 02/23/2005 | CN1585746A Beta-amyloid protein production/secretion inhibitors |
| 02/23/2005 | CN1583735A Enrichment of ligusticum lactone and its preparations |
| 02/23/2005 | CN1583734A Apparatus and process for purifying peach aldehyde by decompressing batch rectifying |
| 02/23/2005 | CN1583733A Bivalent rare earth complex containing oxacyclo substituted indene ligand and its use |
| 02/23/2005 | CN1583722A Heterofluorene highly branched derivative with strong two photon absorption characteristics |
| 02/23/2005 | CN1583711A Oxalate for preparing ambrox or releasing ambrox in cigarette smoke and its use |
| 02/23/2005 | CN1190268C Gas-phase hydrocatalyst of dimethyl maleate |
| 02/22/2005 | US6858744 Heterocyclic ester such as quinoxaline-2-carboxylic acid (4(R) -carbamoyl-1(S)-(3-fluoro-benzyl)-2(S),7-dihydroxy-7-methyl-octyl)-amide, used as preferential antagonists of macrophage inflammatory proteins |
| 02/22/2005 | US6858743 Reacting cyclohexanone with a carboxyl-containing acylating agent to give methyl 2-(2-oxo-cyclohexyl)-2-hydroxyacetate, which are either directly converted to 2-coumarone by catalytic gas-phase dehydrogenation; or through enol-lactone |
| 02/22/2005 | US6858741 Use as pesticides and herbicides |
| 02/22/2005 | US6858740 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses |
| 02/22/2005 | US6858651 2,3-oxidosqualene-lanosterol cyclase inhibitors |
| 02/22/2005 | US6858647 Administering retinoid such as, 6-(3-(1-Adamantyl)-4-methoxy-5-hydroxyphenyl)-2-naphthoic acid benzoic acid for therapy of and prophylaxis of bacterial infection |
| 02/22/2005 | US6858639 3-Arylphenyl sulfide derivative and insecticide and miticide |
| 02/22/2005 | US6858637 Treating rheumatoid arthritis, psoriasis, cardiovascular disease, reperfusion injury, and bronchial asthma; e.g., 2-Methoxynaphthalene-1-carboxylic acid benzyl-indan-2-yl-amide |
| 02/22/2005 | CA2289220C Labeled reagents for use in immunoassays and fluorescent compounds and complexes used therein |
| 02/17/2005 | WO2005015158A2 T1r hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds |
| 02/17/2005 | WO2005014567A1 Mycophenolic acid bismuth salt |
| 02/17/2005 | WO2005014566A1 Benzofuran derivatives useful for treating hyper-proliferative disorders |
| 02/17/2005 | WO2005014565A2 Cis-3,5-disubstituted-dihydro-furan-2-ones and the preparation and use thereof |
| 02/17/2005 | WO2005014508A1 Hydroxy-protecting reagent and method of protecting hydroxy with the same |
| 02/17/2005 | WO2004113278A3 Acylsulfamide inhibitors of factor viia |
| 02/17/2005 | WO2004092115A3 Hydroxamates as therapeutic agents |
| 02/17/2005 | US20050038268 Method for the preparation of enterolactone from matairesinol |
| 02/17/2005 | US20050038123 Process and intermediates to prepare latanoprost |
| 02/17/2005 | US20050038107 Substituted 2-phenyl benzofurans as estrogenic agents |
| 02/17/2005 | US20050038082 Fungicides such as 2-hydroxy-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]-3-phenyl-propionamide; etherification, amidation, sulurization |
| 02/17/2005 | US20050038037 N-(naphth-2-ylaminocarbonylacetyl)- or N-(naphth-2-ylcarbonylamino- acetyl)- piperazine derivatives, e.g., 2-[((4-(ethoxycarbonyl)piperazin-1-yl)carbonylmethyl)carbonyl]aminonaphthalene; useful as antithrombotic agents |
| 02/17/2005 | US20050038021 2,4,5,-trisubstituted phenylketo-enols for use as pesticides and herbicides |
| 02/17/2005 | US20050038014 5'-carbamoyl-1,1' biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 02/17/2005 | US20050038002 Bactericides; antitumor agents; moderators of gene expression; viricides; parasiticides; malaria therapy |
| 02/17/2005 | US20050037995 Carotenoid ester analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury |
| 02/17/2005 | DE10336023A1 New fluorinated heterocycles, e.g. 1,1,8,10-tetrafluoro-2,7-dialk(ox)yl-2,3-dihydro- 1H-9-oxacyclopenta(b)fluorene compounds, used as components of liquid crystalline mixtures for electro-optical displays |
| 02/17/2005 | DE10336016A1 New benzo(b)naphtho(2.3-d)furan compounds with fluorine at position 4, 6 and-or 7 and other substituents at position 3 and-or 8, used as components of liquid crystalline mixtures for electro-optical displays |
| 02/17/2005 | CA2535045A1 T1r hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds |
| 02/16/2005 | EP1507010A2 Control of the gene expression in eukaryotic cells |
| 02/16/2005 | EP1506963A1 Method for the preparation of citalopram |
| 02/16/2005 | EP1506962A2 Nitrogen-containing aromatic heterocycles |
| 02/16/2005 | EP1506951A1 Preparation and application of transhintotalphenolic acid |
| 02/16/2005 | EP1506218A2 Reversible modification of membrane interaction |
| 02/16/2005 | EP1506204A2 1-oxa-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof |
| 02/16/2005 | EP1506182A1 Methods for the manufacture of dihydro-furan-2-one derivatives |
| 02/16/2005 | EP1506166A1 Aminotetralin-derived urea modulators of vanilloid vr1 receptor |
| 02/16/2005 | EP1506158A2 Diamino-functional chalcones |